Clinical Trial Update: Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT Gemcitabine [Phase 1]

View source ↗

Summary

This document reports a Phase 1 trial evaluating intrathecal gemcitabine for neoplastic meningitis, which was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis
• Neoplasms

Drugs mentioned

• Gemzar (gemcitabine)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Meningitis, Neoplasms | Phase 1 | Status: TERMINATED